Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1024.09 - $1201.76 $1.43 Million - $1.68 Million
1,400 Added 10.45%
14,800 $15.6 Million
Q2 2024

Aug 13, 2024

BUY
$883.2 - $1071.19 $1.15 Million - $1.39 Million
1,300 Added 10.74%
13,400 $14.1 Million
Q1 2024

May 13, 2024

BUY
$902.69 - $993.35 $10.9 Million - $12 Million
12,100 New
12,100 $11.6 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.